Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 7/20 | 0.53 |
| ▸ | CACNA1D | Q01668 | 7/20 | 0.53 |
| ▸ | CACNA1S | Q13698 | 7/20 | 0.53 |
| ▸ | CACNA1C | Q13936 | 7/20 | 0.53 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.51 |
| ▸ | THPO | P40225 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5795319 | 0.88 | LMNA (0.51) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5911405 | 0.87 | CACNA1C (0.47) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5911603 | 0.86 | CACNA1C (0.46) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5767258 | 0.86 | ALDH1A1 (0.47) | KMT2AMAPTLMNAALDH1A1L3MBTL1 | |
| SCHEMBL5792331 | 0.85 | CACNA1F (0.49) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5911571 | 0.85 | MEN1 (0.45) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5912066 | 0.84 | CACNA1C (0.48) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5767096 | 0.84 | MEN1 (0.46) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5911409 | 0.84 | MEN1 (0.45) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 | |
| SCHEMBL5911511 | 0.84 | CACNA1C (0.44) | CACNA1FCACNA1DCACNA1SCACNA1CMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060116390-A1 | Hepatitis c virus inhibitors | LG LIFE SCIENCES LTD. (KR) | 2006-06-01 | — | — | US | disclosed |
| EP-1633725-A1 | HEPATITIS C VIRUS INHIBITORS | LG Life Sciences Ltd. (KR) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004111013-A1 | HEPATITIS C VIRUS INHIBITORS | LG LIFE SCIENCES LTD. (KR) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116390-A1 | Hepatitis c virus inhibitors | HAVCR2, LIPC, FABP1 | CACNA1F 4796/4885CACNA1D 4868/4885CACNA1S 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.